Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2009 Outpatient Commitment: A Treatment Tool for the Mentally Ill? Commentary 2 Ann Hackman, MD Benefits and risks of outpatient commitment are a means for managing mental illness in patients who are homeless. Virtual Mentor. 2009;11(1):9-12. doi: 10.1001/virtualmentor.2009.11.1.ccas1-0901. Case and Commentary Jan 2009 Hospital Resources: A Practical Treatment Plan for Homeless Patients, Commentary 2 David Buchanan, MD, MS and Sharad Jain, MD This case illustrates how emergency physicians find themselves with an empty toolbox and must compromise to meet their responsibilities to patients and themselves. Virtual Mentor. 2009;11(1):23-25. doi: 10.1001/virtualmentor.2009.11.1.ccas3-0901. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 Case and Commentary Apr 2003 When Disability Is in Question Guy Micco, MD A patient and physician must have a strong line of communication when dealing with pain that has no clear causes. Virtual Mentor. 2003;5(4):129-132. doi: 10.1001/virtualmentor.2003.5.4.ccas4-0304 Case and Commentary Jun 2003 Cultural Differences at the End of Life Diane Rapaport, MD Physicians must be mindful of how cultural attitudes regarding death and end-of-life care that will impact patients' decisions regarding a loved one. Virtual Mentor. 2003;5(6):201-204. doi: 10.1001/virtualmentor.2003.5.6.ccas1-0306. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408. Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Next page Next › Last page Last »
Case and Commentary Jan 2009 Outpatient Commitment: A Treatment Tool for the Mentally Ill? Commentary 2 Ann Hackman, MD Benefits and risks of outpatient commitment are a means for managing mental illness in patients who are homeless. Virtual Mentor. 2009;11(1):9-12. doi: 10.1001/virtualmentor.2009.11.1.ccas1-0901.
Case and Commentary Jan 2009 Hospital Resources: A Practical Treatment Plan for Homeless Patients, Commentary 2 David Buchanan, MD, MS and Sharad Jain, MD This case illustrates how emergency physicians find themselves with an empty toolbox and must compromise to meet their responsibilities to patients and themselves. Virtual Mentor. 2009;11(1):23-25. doi: 10.1001/virtualmentor.2009.11.1.ccas3-0901.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
Case and Commentary Apr 2003 When Disability Is in Question Guy Micco, MD A patient and physician must have a strong line of communication when dealing with pain that has no clear causes. Virtual Mentor. 2003;5(4):129-132. doi: 10.1001/virtualmentor.2003.5.4.ccas4-0304
Case and Commentary Jun 2003 Cultural Differences at the End of Life Diane Rapaport, MD Physicians must be mindful of how cultural attitudes regarding death and end-of-life care that will impact patients' decisions regarding a loved one. Virtual Mentor. 2003;5(6):201-204. doi: 10.1001/virtualmentor.2003.5.6.ccas1-0306.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408.